WHO approved use of Sinopharm vaccine

WHO approved use of Sinopharm vaccine

The Sinopharm vaccine has been approved by the World Health Organization (WHO) for use against COVID-19, according to Armenia’s Ministry of Health.

A clinical trial of the third phase of Sinopharm vaccine showed that the second dose of the vaccine was 79% effective 14 days after the second dose against symptomatic SARS-CoV-2 infection.

And the efficiency of hospitalization prevention is 79%.

Sections

Views

logo

Official broadcaster of the Eurovision Song Contest

Eurovision

Download the app

qr
App StoreGoogle Play
FacebookXInstagramYouTubeLinkedIn

©2026 1tv.am

Designed by MATEMAT